Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: John Dwyer who wrote (647)	8/10/1999 10:36:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4474

tax purposes...yeah, that was my plan, convert the IRA to a Roth. If share prices move partly based on mood, and one can count on stocks being cheap at the maximum point of pessimism...then we are there right now on Ariad. Of course I've always felt there could be another shake out if we break below a buck and delisting fears increase. You would not think that a company could have management who could so completely fall into such a big trap, these fellas make terrific salaries, you would hope they would make better choices. No matter...I've said this all a dozen times, let's see if Ariad can do something nice for shareholders for a change, they seem to do miracles in the lab--maybe they're clever enough not to kill the company. Much thanks to everybody who posted on the floorless, it's got me fairly rattled, but I think we all know Ariad is worth more than 20-25M, maybe five times that...and it'll probably work out okay with time-- folks usually don't make the same mistake twice, Berger will probably go to Hoechst for help before he goes back to the 'bad guys' again.